Literature DB >> 9665489

Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.

J Saarnio1, S Parkkila, A K Parkkila, K Haukipuro, S Pastoreková, J Pastorek, M I Kairaluoma, T J Karttunen.   

Abstract

Carbonic anhydrase isoenzyme IX, MN/CA IX, is a recently discovered member of the carbonic anhydrase (CA) gene family with a suggested function in acid-base balance, intercellular communication, and cell proliferation. Increased expression of MN/CA IX has been observed with certain epithelial tumors. We investigated the expression of MN/CA IX in 69 colorectal neoplasms, consisting of 1 juvenile polyp, 8 hyperplastic polyps, 39 adenomatous lesions, 21 carcinomas, and 7 metastases. Tissue sections were immunostained with a monoclonal antibody specific to MN/CA IX. The proliferative activity of the tumor cells was evaluated by Ki-67 antigen immunoreactivity. The hyperplastic polyps showed a weak or moderate reaction for MN/CA IX only in the cryptal epithelium, as did the normal intestinal mucosa. The adenomas showed immunoreactivity mainly in the superficial part of the mucosa, whereas the distribution in the carcinomas and metastases was more diffuse. Comparative immunostaining of serial sections for Ki-67, a well established marker of cell proliferation, confirmed that MN/CA IX is expressed in areas with high proliferative capacity. Our results show abnormal MN/CA IX expression in colorectal neoplasms, suggesting its involvement in their pathogenesis. The co-occurrence of MN/CA IX and Ki-67 in the same tumor cells indicates its potential for use as a marker of increased proliferation in the colorectal mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665489      PMCID: PMC1852958          DOI: 10.1016/S0002-9440(10)65569-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

Review 1.  Carbonic anhydrase in the alimentary tract. Roles of the different isozymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal.

Authors:  S Parkkila; A K Parkkila
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

Review 2.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Expression of MaTu-MN protein in human tumor cultures and in clinical specimens.

Authors:  J Závada; Z Závadová; S Pastoreková; F Ciampor; J Pastorek; V Zelník
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

4.  Functional diversity, conservation, and convergence in the evolution of the alpha-, beta-, and gamma-carbonic anhydrase gene families.

Authors:  D Hewett-Emmett; R E Tashian
Journal:  Mol Phylogenet Evol       Date:  1996-02       Impact factor: 4.286

5.  Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships.

Authors:  R Opavský; S Pastoreková; V Zelník; A Gibadulinová; E J Stanbridge; J Závada; R Kettmann; J Pastorek
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

6.  Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.

Authors:  S Y Liao; E J Stanbridge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-07       Impact factor: 4.254

7.  Carbonic anhydrase isoenzymes II and I are present in the zona glomerulosa cells of the human adrenal gland.

Authors:  A K Parkkila; S Parkkila; T Juvonen; H Rajaniemi
Journal:  Histochemistry       Date:  1993-01

8.  Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas.

Authors:  S Y Liao; C Brewer; J Závada; J Pastorek; S Pastorekova; A Manetta; M L Berman; P J DiSaia; E J Stanbridge
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

9.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

Authors:  J Pastorek; S Pastoreková; I Callebaut; J P Mornon; V Zelník; R Opavský; M Zat'ovicová; S Liao; D Portetelle; E J Stanbridge
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

Review 10.  Human carbonic anhydrases and carbonic anhydrase deficiencies.

Authors:  W S Sly; P Y Hu
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

View more
  83 in total

1.  Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors.

Authors:  A Kivelä; S Parkkila; J Saarnio; T J Karttunen; J Kivelä; A K Parkkila; A Waheed; W S Sly; J H Grubb; G Shah; O Türeci; H Rajaniemi
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.

Authors:  Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hiraki; Hirokazu Noshiro; Kohji Miyazaki
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  The role of carbonic anhydrases in tumors.

Authors:  A Nógrádi
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

Review 4.  Carbonic anhydrases as disease markers.

Authors:  Sabina Zamanova; Ahmed M Shabana; Utpal K Mondal; Marc A Ilies
Journal:  Expert Opin Ther Pat       Date:  2019-06-17       Impact factor: 6.674

5.  Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.

Authors:  Minna Nortunen; Heikki Huhta; Olli Helminen; Seppo Parkkila; Joonas H Kauppila; Tuomo J Karttunen; Juha Saarnio
Journal:  Virchows Arch       Date:  2018-07-31       Impact factor: 4.064

6.  Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

Authors:  S Ivanov; S Y Liao; A Ivanova; A Danilkovitch-Miagkova; N Tarasova; G Weirich; M J Merrill; M A Proescholdt; E H Oldfield; J Lee; J Zavada; A Waheed; W Sly; M I Lerman; E J Stanbridge
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

7.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

Review 8.  Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.

Authors:  Emma Langella; Martina Buonanno; Giuseppina De Simone; Simona Maria Monti
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

9.  Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.

Authors:  Annelies Debucquoy; Laurence Goethals; Louis Libbrecht; Christiaan Perneel; Karel Geboes; Nadine Ectors; William H McBride; Karin Haustermans
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

10.  Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.

Authors:  Yong Sang Hong; Hyeon Jin Cho; Sun Young Kim; Kyung Hae Jung; Ji Won Park; Hyo Seong Choi; Jae Hwan Oh; Byung Chang Kim; Dae Kyung Sohn; Dae Yong Kim; Hee Jin Chang
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.